Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.24 USD | +1.92% | +8.72% | +12.77% |
Mar. 13 | Sector Update: Health Care Stocks Ease Wednesday Afternoon | MT |
Mar. 13 | CorMedix Remains Encouraged on DefenCath Opportunity, RBC Says | MT |
Business Summary
Number of employees: 83
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Todisco
CEO | Chief Executive Officer | 48 | 22-03-17 |
Mathew David
DFI | Director of Finance/CFO | 47 | 20-05-10 |
Tushar Mukherjee
CTO | Chief Tech/Sci/R&D Officer | - | 21-12-31 |
General Counsel | - | Dec. 11 | |
Erin Mistry
PRN | Corporate Officer/Principal | 43 | 19-12-31 |
Frank Raffaele
PRN | Corporate Officer/Principal | - | 22-05-11 |
Donna Ucci
PRN | Corporate Officer/Principal | - | 22-05-11 |
Corporate Officer/Principal | 45 | 18-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Myron Kaplan
CHM | Chairman | 79 | 16-04-26 |
Steven Lefkowitz
DFI | Director of Finance/CFO | 68 | 11-08-14 |
Alan Dunton
BRD | Director/Board Member | 70 | 19-02-28 |
Janet Dillione
BRD | Director/Board Member | 65 | 15-08-05 |
Joseph Todisco
CEO | Chief Executive Officer | 48 | 22-03-17 |
Gregory Duncan
BRD | Director/Board Member | 59 | 20-11-01 |
Robert Stewart
BRD | Director/Board Member | 56 | 23-04-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 54,981,102 | 54,415,049 ( 98.97 %) | 0 | 98.97 % |
Stock B | 0 | 181,622 | 0 | 0 |
Company contact information
CorMedix, Inc.
300 Connell Drive Suite 4200
07922, Berkeley Heights
+908 517 9500
http://www.cormedix.comSector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.77% | 233M | |
+13.52% | 9.63B | |
-7.87% | 5.37B | |
+12.50% | 4.28B | |
+18.09% | 3.71B | |
+42.95% | 2.91B | |
-19.01% | 2.54B | |
-20.66% | 2.37B | |
+17.86% | 1.87B | |
-0.50% | 1.64B |
- Stock
- Equities
- Stock CorMedix Inc. - Nasdaq
- Company CorMedix Inc.